|
Adele Oliva is a Partner at Quaker BioVentures a venture capital firm dedicated to investing in life science companies located in the Mid-Atlantic region and contiguous states. She joined Quaker in June 2007. Previously, Adele was a Partner at Apax Partners which she had joined in 1997 following her selection as a Ewing Marion Kauffman Fellow in Venture Capital and Entrepreneurship. At Apax, she co-led the Healthcare Group in the United States with a focus on specialty pharmaceuticals and medical devices/products. Prior to Apax, she held positions in marketing and business development with Baxter Healthcare in the company's Cardiovascular and I.V. Systems divisions. Adele's experience also includes positions with Ogilvy & Maher, where she was employed in the firm's office in Hungary, and with CoreStates Financial Corp., where she worked as a commercial lending officer and senior financial analyst. In addition to EKR Therapeutics, her experience as a Board member includes Prometheus Labs, SkinMedica, Esprit Pharma, Alliance Healthcare Solutions, ESP Pharma., and Xanodyne Pharmaceuticals. Adele is a graduate of Saint Joseph's University and earned an M.B.A. in Marketing from Cornell University, where she was awarded a Fried Fellowship. | 